Literature DB >> 31995001

A Hidden Human Proteome Signature Characterizes the Epithelial Mesenchymal Transition Program.

Daniele Vergara1, Tiziano Verri1, Marina Damato1, Marco Trerotola2, Pasquale Simeone3, Julien Franck4, Isabelle Fournier4, Michel Salzet4, Michele Maffia1.   

Abstract

BACKGROUND: Molecular changes associated with the initiation of the epithelial to mesenchymal transition (EMT) program involve alterations of large proteome-based networks. The role of protein products mapping to non-coding genomic regions is still unexplored.
OBJECTIVE: The goal of this study was the identification of an alternative protein signature in breast cancer cellular models with a distinct expression of EMT markers.
METHODS: We profiled MCF-7 and MDA-MB-231 cells using liquid-chromatography mass/spectrometry (LCMS/ MS) and interrogated the OpenProt database to identify novel predicted isoforms and novel predicted proteins from alternative open reading frames (AltProts).
RESULTS: Our analysis revealed an AltProt and isoform protein signature capable of classifying the two breast cancer cell lines. Among the most highly expressed alternative proteins, we observed proteins potentially associated with inflammation, metabolism and EMT.
CONCLUSION: Here, we present an AltProts signature associated with EMT. Further studies will be needed to define their role in cancer progression. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  Epithelial mesenchymal transition; OpenProt database; alternative proteins; breast cancer; predicted isoforms; proteome.

Year:  2020        PMID: 31995001     DOI: 10.2174/1381612826666200129091610

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  1 in total

1.  In-depth proteomics analysis of sentinel lymph nodes from individuals with endometrial cancer.

Authors:  Soulaimane Aboulouard; Maxence Wisztorski; Marie Duhamel; Philippe Saudemont; Tristan Cardon; Fabrice Narducci; Anne-Sophie Lemaire; Firas Kobeissy; Eric Leblanc; Isabelle Fournier; Michel Salzet
Journal:  Cell Rep Med       Date:  2021-06-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.